Research Article

Systemic inflammatory markers in vestibular neuritis and BPPV: A single-center retrospective study

Volume: 6 Number: 1 March 12, 2026

Systemic inflammatory markers in vestibular neuritis and BPPV: A single-center retrospective study

Abstract

Aims: This study aimed to compare systemic inflammatory markers, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), derived NLR (dNLR), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI), in patients with vestibular neuritis (VN) and benign paroxysmal positional vertigo (BPPV) and to evaluate their potential role in differential diagnosis.

Methods: In this retrospective study, 109 patients diagnosed with VN (n=52) or BPPV (n=57) at Kastamonu Training and Research Hospital were included between January 2024 and December 2024. Demographic characteristics, clinical data, and laboratory parameters (leukocyte, neutrophil, lymphocyte, monocyte, platelet, CRP, and albumin levels) were recorded. NLR, dNLR, MLR, PLR, SII [(platelet × neutrophil)/lymphocyte], and SIRI [(neutrophil × monocyte)/lymphocyte] were calculated.

Results: The two groups were similar regarding age and sex distribution; however, bilateral involvement was significantly more common in the BPPV group (p=0.004). The VN group showed significantly higher leukocyte (p=0.027) and neutrophil (p=0.004) counts and significantly lower albumin levels (p=0.001). Among inflammatory markers, NLR (p=0.012), SII (p=0.023) and SIRI (p=0.035) were found to be significantly higher in VN patients than in BPPV patients.

Conclusion: The significant increase in NLR, SII, and SIRI levels in VN patients compared with BPPV patients suggests a more prominent role of inflammatory mechanisms in the pathogenesis of vestibular neuritis. These readily available and inexpensive biomarkers may serve as supportive tools in the differential diagnosis of peripheral vertigo in clinical practice.

Keywords

References

  1. 1. Petri M, Chirila M, Bolboaca S,et al. Unilateral peripheral vestibular disorders in the emergency room of the ENT Department of Cluj-Napoca, Romania. Clujul Med. 2015;88(2):181-187. doi:10.15386/cjmed-412
  2. 2. Hung SH, Xirasagar S, Dang LH, et al. Trends in the incidence of peripheral vestibular disorders: a Nationwide population-based study. Front Neurol. 2023;14:1322199. doi:10.3389/fneur.2023.1322199
  3. 3. von Brevern M, Bertholon P, Brandt T, et al. Benign paroxysmal positional vertigo: Diagnostic criteria. J Vestib Res. 2015;25(3-4):105-117. doi:10.3233/VES-150553
  4. 4. Bae CH, Na HG, Choi YS. Current diagnosis and treatment of vestibular neuritis: a narrative review. J Yeungnam Med Sci. 2022;39(2):81-88. doi:10.12701/yujm.2021.01228
  5. 5. Bucak A, Ulu S, Oruc S, et al. Neutrophil-to-lymphocyte ratio as a novel-potential marker for predicting prognosis of Bell palsy. Laryngoscope. 2014;124(7):1678-1681. doi:10.1002/lary.24551
  6. 6. Ferroni P, Riondino S, Formica V, et al. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio. Int J Cancer. 2015;136(5):1234-1240. doi:10.1002/ijc.29076
  7. 7. Özler GS. Increased neutrophil-lymphocyte ratio in patients with idiopathic sudden sensorineural hearing loss. J Craniofac Surg. 2014;25(3):e260-263. doi:10.1097/SCS.0000000000000565
  8. 8. Chung JH, Lim J, Jeong JH, Kim KR, Park CW, Lee SH. The significance of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in vestibular neuritis. Laryngoscope. 2015;125(7):E257-261. doi:10.1002/lary.25204

Details

Primary Language

English

Subjects

Neurology and Neuromuscular Diseases

Journal Section

Research Article

Publication Date

March 12, 2026

Submission Date

September 22, 2025

Acceptance Date

October 23, 2025

Published in Issue

Year 2026 Volume: 6 Number: 1

APA
Özen Gökmuharremoğlu, Ö., & Aydin, Y. (2026). Systemic inflammatory markers in vestibular neuritis and BPPV: A single-center retrospective study. Kastamonu Medical Journal, 6(1), 91-97. https://doi.org/10.66235/kumj.1906837
AMA
1.Özen Gökmuharremoğlu Ö, Aydin Y. Systemic inflammatory markers in vestibular neuritis and BPPV: A single-center retrospective study. Kastamonu Medical Journal. 2026;6(1):91-97. doi:10.66235/kumj.1906837
Chicago
Özen Gökmuharremoğlu, Özge, and Yusuf Aydin. 2026. “Systemic Inflammatory Markers in Vestibular Neuritis and BPPV: A Single-Center Retrospective Study”. Kastamonu Medical Journal 6 (1): 91-97. https://doi.org/10.66235/kumj.1906837.
EndNote
Özen Gökmuharremoğlu Ö, Aydin Y (March 1, 2026) Systemic inflammatory markers in vestibular neuritis and BPPV: A single-center retrospective study. Kastamonu Medical Journal 6 1 91–97.
IEEE
[1]Ö. Özen Gökmuharremoğlu and Y. Aydin, “Systemic inflammatory markers in vestibular neuritis and BPPV: A single-center retrospective study”, Kastamonu Medical Journal, vol. 6, no. 1, pp. 91–97, Mar. 2026, doi: 10.66235/kumj.1906837.
ISNAD
Özen Gökmuharremoğlu, Özge - Aydin, Yusuf. “Systemic Inflammatory Markers in Vestibular Neuritis and BPPV: A Single-Center Retrospective Study”. Kastamonu Medical Journal 6/1 (March 1, 2026): 91-97. https://doi.org/10.66235/kumj.1906837.
JAMA
1.Özen Gökmuharremoğlu Ö, Aydin Y. Systemic inflammatory markers in vestibular neuritis and BPPV: A single-center retrospective study. Kastamonu Medical Journal. 2026;6:91–97.
MLA
Özen Gökmuharremoğlu, Özge, and Yusuf Aydin. “Systemic Inflammatory Markers in Vestibular Neuritis and BPPV: A Single-Center Retrospective Study”. Kastamonu Medical Journal, vol. 6, no. 1, Mar. 2026, pp. 91-97, doi:10.66235/kumj.1906837.
Vancouver
1.Özge Özen Gökmuharremoğlu, Yusuf Aydin. Systemic inflammatory markers in vestibular neuritis and BPPV: A single-center retrospective study. Kastamonu Medical Journal. 2026 Mar. 1;6(1):91-7. doi:10.66235/kumj.1906837

Kastamonu Medical Journal is licensed under a Creative Commons CC BY-NC-ND 4.0 International License.

This is an open-access journal distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0). 

Click here to get help about article submission processes and "Copyright Transfer Form".